GSA Capital Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Buy |
6,097
+1,028
| +20% | +$64.9K | 0.03% | 1108 |
|
|
2025
Q1 | $269K | Buy |
+5,069
| New | +$269K | 0.02% | 1224 |
|
|
2023
Q4 | – | Sell |
-16,465
| Closed | -$377K | – | 1869 |
|
|
2023
Q3 | $377K | Sell |
16,465
-52,099
| -76% | -$1.19M | 0.03% | 961 |
|
|
2023
Q2 | $1.13M | Buy |
+68,564
| New | +$1.13M | 0.11% | 245 |
|
|
2023
Q1 | – | Sell |
-7,451
| Closed | -$217K | – | 1878 |
|
|
2022
Q4 | $217K | Sell |
7,451
-1,641
| -18% | -$47.8K | 0.03% | 1138 |
|
|
2022
Q3 | $223K | Sell |
9,092
-14,055
| -61% | -$345K | 0.03% | 1141 |
|
|
2022
Q2 | $96K | Buy |
+23,147
| New | +$96K | 0.01% | 1226 |
|